HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.
5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Myocardial Revascularization
Myocardial Revascularization
Myocardial revascularization, a critical procedure in cardiovascular medicine, aims to restore blood flow to the heart muscle, particularly in cases of coronary artery disease. This surgical intervention typically involves bypass grafting or angioplasty to alleviate blockages in coronary arteries, enhancing blood supply to the heart. Myocardial revascularization plays a pivotal role in managing ischemic heart conditions, minimizing chest pain, and reducing the risk of heart attacks. This procedure, often performed with meticulous precision, contributes significantly to improving cardiac function and overall patient well-being, representing a crucial aspect of contemporary cardiovascular care.
Committee Members
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States Heart Congress 2027 Speakers
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain